Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Haller, Hermann, Ito, Sadayoshi, Izzo, Joseph L., Januszewicz, Andrzej, Katayama, Shigehiro, Menne, Jan, Mimran, Albert, Rabelink, Ton J. +4 more·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1007994

Cited by (793)

Items 101–200 of 793

Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report
Matthew R. Weir, Jay Ian Lakkis, Bernard G. Jaar, Michael V. Rocco, Michael Jin Choi, Holly Kramer, Elaine Ku · 2018 · American Journal of Kidney Diseases
Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: A systematic review for a KDOQI clinical practice guideline
Slinin, Yelena, Ishani, Areef, Rector, Thomas, Fitzgerald, Patrick, MacDonald, Roderick, Tacklind, James, Rutks, Indulis, Wilt, Timothy J. · 2012 · American Journal of Kidney Diseases
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
Houda Tamouza, Jonathan Chemouny, Leona Raskova Kafkova, Laureline Berthelot, Martin Flamant, Marie Demion, Laurent Mesnard, Étienne Paubelle, Francine Walker, Bruce A. Julian et al. · 2012 · Kidney International
Effects of blood-pressure-lowering treatment in hypertension
Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
Angiotensin II Blockade and Renal Protection
Hiroyuki Kobori, Hirohito Mori, Tsutomu Masaki, Akira Nishiyama · 2013 · Current Pharmaceutical Design
Mortality Rates in Trials of Subjects With Type 2 Diabetes
Ebrahim Barkoudah, Hicham Skali, Hajime Uno, Scott David Solomon, Marc Alan Pfeffer · 2012 · Journal of the American Heart Association
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
Claudia Pontillo, Zhen‐Yu Zhang, Joost Peter Schanstra, Lotte Jacobs, Petra Zürbig, Lutgarde Thijs, Adela Ramírez‐Torres, Hiddo J.L. Heerspink, Morten Kofod Lindhardt, Ronald Klein et al. · 2017 · Kidney International Reports
Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study
Mickaël Basson, Myriam Mezzarobba, Alain Weill, Philippe Ricordeau, Hubert Allemand, François Alla, Franck Carbonnel · 2015 · Gut
Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)
on behalf of the C-STRIDE study group, Jun Yuan, Xinrong Zou, Si-Ping Han, Hong Cheng, Lan Wang, Jinwei Wang, Luxia Zhang, Ming‐Hui Zhao, Xiaoqin Wang · 2017 · BMC Nephrology
Serum integrative omics reveals the landscape of human diabetic kidney disease
Shijia Liu, Yuan Gui, Mark S. Wang, Lu Zhang, Tingting Xu, Yuchen Pan, Ke Zhang, Ying Yu, Liangxiang Xiao, Yi Qiao et al. · 2021 · Molecular Metabolism
Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
Ping Li, Yiping Chen, Jianping Liu, Jing Hong, Yueyi Deng, Fang Yang, Jin Xiu-ping, Jing Sheng Gao, Jing Li, Hui Fang et al. · 2015 · PLoS ONE
The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis
Tadashi Toyama, Kengo Furuichi, Toshiharu Ninomiya, Miho Shimizu, Akinori Hara, Yasunori Iwata, Shuichi Kaneko, Takashi Wada · 2013 · PLoS ONE
Microalbuminuria: A parameter that has changed diabetes care
Hans‐Henrik Parving, Frederik Persson, Peter R Rossing · 2014 · Diabetes Research and Clinical Practice
Blood pressure control in Italy
Giuliano Tocci, Enrico Agabiti Rosei, Ettore Ambrosioni, Claudio Borghi, Claudio Ferri, Andrea Ferrucci, Giuseppe Mancia, Alberto Morganti, Roberto Pontremoli, Bruno Trimarco et al. · 2012 · Journal of Hypertension
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
Thomas G. von Lueder, Henry Krum · 2012 · Cardiovascular Drugs and Therapy
MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the ‘Asian Indian phenotype’
Prabu Paramasivam, Sophie Rome, Sathishkumar Chandrakumar, Caroline Gastebois, Emmanuelle Meugnier, Viswanathan Mohan, Muthuswamy Balasubramanyam · 2018 · Diabetes & Metabolism
Prediction of diabetic kidney disease with machine learning algorithms, upon the initial diagnosis of type 2 diabetes mellitus
Angier O. Allen, Zohora Iqbal, Abigail Green‐Saxena, Myrna Hurtado, Jana L. Hoffman, Qingqing Mao, Ritankar Das · 2022 · BMJ Open Diabetes Research & Care
Improvements in the Management of Diabetic Nephropathy
Evangelia C. Dounousi, Αnila Duni, Konstantinos Leivaditis, Vasilios Vaios, Theodoros Eleftheriadis, Vassilios Liakopoulos · 2015 · The Review of Diabetic Studies
Effects of blood pressure lowering treatment in hypertension
Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
Chia‐Hsuin Chang, Jou‐Wei Lin, Li‐Chiu Wu, Mei‐Shu Lai · 2011 · Journal of Clinical Oncology
Blood pressure control for diabetic retinopathy
V. Diana, Genie Han, Samuel A. Abariga, Gina G. Sleilati, S. Swaroop Vedula, Barbara S. Hawkins · 2023 · Cochrane Database of Systematic Reviews
Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease
Sharon Chia-Ju Chen, J.-M. Chang, W.-C. Liu, J.-C. Huang, Jer‐Chia Tsai, Ming‐Yen Lin, Ho‐Ming Su, Shang Jyh Hwang, H.-C. Chen · 2011 · Nephrology Dialysis Transplantation
Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues
SIIA Task Force, Claudio Borghi, SIF Task Force, Francesco Rossi · 2015 · High Blood Pressure & Cardiovascular Prevention
A significant portion of college students are not aware of HPV disease and HPV vaccine recommendations
Caitlyn Kellogg, Janella Shu, Ayana Arroyo, Ngoc Tuyen Dinh, Nia Wade, Elizabeth Sanchez, Ozlem Equils · 2019 · Human Vaccines & Immunotherapeutics
The Kidney in Type 2 Diabetes Therapy
Hiddo J.L. Heerspink, Dick de Zeeuw · 2011 · The Review of Diabetic Studies
Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
María Encarnación Rodríguez-Ortiz, Claudia Pontillo, Mariano Rodríguez, Petra Zürbig, Harald Mischak, Alberto Ortíz · 2018 · Scientific Reports
Time course and mechanisms of the anti‐hypertensive and renal effects of liraglutide treatment
von Scholten, B. J., Lajer, M., Goetze, J. P., Persson, F., Rossing, P. · 2015 · Diabetic Medicine
Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes
Bauke Schievink, Tobias F. Kröpelin, Skander Mulder, H.‐H. Parving, Giuseppe Remuzzi, Jamie P. Dwyer, Pepijn Vemer, Dick de Zeeuw, Hiddo J.L. Heerspink · 2015 · Diabetes Obesity and Metabolism
Renin–Angiotensin System Blocking Drugs
Nicolás Roberto Robles, Isis Cerezo, Román Hernández‐Gallego · 2013 · Journal of Cardiovascular Pharmacology and Therapeutics
Cardiovascular Disease and Diabetic Kidney Disease
Muhammad Maqbool, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm · 2018 · Seminars in Nephrology
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria
Giuseppe Mulè, Antonella Castiglia, Claudia Cusumano, Emilia Scaduto, Giulio Geraci, Dario C. Altieri, Epifanio Di Natale, Onofrio Cacciatore, Giovanni Cerasola, Santina Cottone · 2016 · Advances in experimental medicine and biology
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
Giovanna Leoncini, Francesca Chiara Viazzi, Salvatore De Cosmo, Giuseppina Tiziana Russo, Paola Fioretto, Roberto Pontremoli · 2020 · Journal of Nephrology
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
María Vanessa Pérez-Gómez, María Dolores Sánchez-Niño, Ana Belen Sanz, Catalina Martín-Cleary, Marta Ruiz‐Ortega, Jesús Egido, Juan F. Navarro‐González, Alberto Ortíz, Beatriz Fernández‐Fernández · 2015 · Journal of Clinical Medicine
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
Yasuhiko Sakata, Nobuyuki Shiba, JUN C. TAKAHASHI, Satoshi Miyata, Kotaro Nochioka, Masanobu Miura, Tsuyoshi Takada, Chiharu Saga, Tsuyoshi Shinozaki, Masafumi Sugi et al. · 2015 · European Heart Journal
Plasma Aldosterone Levels and Development of Insulin Resistance
Eita Kumagai, Hisashi Adachi, David R. Jacobs, Yuji Hirai, Mika Enomoto, Ako Fukami, Maki Otsuka, Shunichi Kumagae, Yasuki Nanjo, Kuniko Yoshikawa et al. · 2011 · Hypertension
Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
Masumi Kamiyama, Maki Urushihara, Takashi Morikawa, Yoshio Konishi, Masahito Imanishi, Akira Nishiyama, Hiroyuki Kobori · 2013 · International Journal of Molecular Sciences
Morbus Diureticus in the Elderly: Epidemic Overuse of a Widely Applied Group of Drugs
Martin Wehling · 2013 · Journal of the American Medical Directors Association
Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años
Pablo Aschner Montoya, Óscar Múñoz, Diana Marcela Girón Cardozo, Olga Milena García, Daniel Gerardo Fernandez-Ávila, Luz Ángela Casas, Luisa Fernanda Bohórquez, Clara María Arango Toro, Liliana Carvajal, Doris Ramírez de Peña et al. · 2016 · Colombia medica
Cardinal Role of the Intrarenal Renin-Angiotensin System in the Pathogenesis of Diabetic Nephropathy
Hiroyuki Kobori, Masumi Kamiyama, Lisa M. Harrison‐Bernard, Luis Gabriel Navar · 2013 · Journal of Investigative Medicine
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials
Sripal Bangalore, Sunil Kumar, Alexander Volodarskiy, Franz H. Messerli · 2012 · Heart
The urinary proteome as correlate and predictor of renal function in a population study
Yumei Gu, Lutgarde Thijs, Yan-Ping Liu, Zhen‐Yu Zhang, Lotte Jacobs, Thomas Koeck, Petra Zürbig, Ralf Lichtinghagen, Korbinian Brand, Tatiana Kuznetsova et al. · 2014 · Nephrology Dialysis Transplantation
Pharmacotherapy for hypertension in adults 60 years or older
Vijaya Manav Musini, Aaron M Tejani, Ken L. Bassett, Lorri J Puil, James M Wright · 2019 · Cochrane Database of Systematic Reviews
Current challenges in the clinical management of hypertension
Luis Miguel Ruilope · 2011 · Nature Reviews Cardiology
Clinical application of urinary proteomics/peptidomics
Amaya Albalat, Harald Mischak, William Mullen · 2011 · Expert Review of Proteomics
Systolic Blood Pressure Levels Among Adults With Hypertension and Incident Cardiovascular Events
Carlos J. Rodríguez, Katrina R. Swett, Sunil Kumar Agarwal, Aaron R. Folsom, Ervin Ray Fox, Laura R. Loehr, Hanyu Ni, Wayne D. Rosamond, Patricia P. Chang · 2014 · JAMA Internal Medicine
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
L. Lozano Maneiro, Adriana Puente-García · 2015 · Journal of Clinical Medicine
Treatment of Hypertension in Chronic Kidney Disease
Rigas Kalaitzidis, Moses Elisaf · 2018 · Current Hypertension Reports
Rethinking value in health innovation: from mystifications towards prescriptions
Mariana Mazzucato, Victor Roy · 2018 · Journal of Economic Policy Reform
The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review
Anastasia Ptinopoulou, Maria I. Pikilidou, Anastasios N. Lasaridis · 2012 · Hypertension Research
Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort
Zubaidah Zakaria, Muhamad Farid Zulkifle, Wan Atiqah Najiah Wan Hasan, Azlah Kamilah Azhari, Sayyidi Hamzi Abdul Raub, Jeyanthy Eswaran, M. Soundararajan, Sharifah Noor Akmal Syed Husain · 2019 · OncoTargets and Therapy
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Csaba András Dézsi · 2016 · American Journal of Cardiovascular Drugs
Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease
Xianhui Liang, Pei Wang, Bohan Chen, Yan Ge, Athena Y. Gong, Bryce Flickinger, Deepak K Malhotra, Lijuan Wang, Lance D. Dworkin, Zhangsuo Liu et al. · 2019 · Kidney International
Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients
Tatsumi Moriya, Shiro Tanaka, Ryo Kawasaki, Yasuo Ohashi, Yasuo Akanuma, Nobuhiro Yamada, Hirohito Sone, Hidetoshi Yamashita, Shigehiro Katayama, for the Japan Diabetes Complications Study Group · 2013 · Diabetes Care
Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis
Sandip Chaugai, Wen Yeng Meng, Amir A. Sepehry · 2016 · Journal of Cardiovascular Pharmacology and Therapeutics
Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
Judit Hodrea, Dora Bianka Balogh, Ádám Hosszú, Lilla Lénárt, Balázs Besztercei, Sándor Kőszegi, Nadja Sparding, Federica Genovese, Laszlo Jozsef Wagner, Attila Jozsef Szabo et al. · 2020 · American Journal of Physiology-Renal Physiology
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
Hui Lin, Frank Geurts, Luise Hassler, DANIEL C. BATLLE, Katrina M. Mirabito Colafella, Kate M. Denton, Jia L. Zhuo, Xiao C. Li, Nirupama Ramkumar, Masahiro Koizumi et al. · 2022 · Pharmacological Reviews
Inadequacy of cardiovascular risk factor management in chronic kidney transplantation – evidence from the FAVORIT study
Myra A. Carpenter, Matthew R. Weir, Deborah Adey, Andrew A. House, Andrew G. Bostom, John W. Kusek · 2012 · Clinical Transplantation
Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension
Jose Maria Pascual, Enrique Rodilla, José A. Costa, Miguel Garcia-Escrich, Carmen González, Josep Redón · 2014 · Hypertension
Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: a systematic review
Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik · 2016 · Journal of the Renin-Angiotensin-Aldosterone System
Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease
Kevin O’Fee, Elena Deych, Oriana Ciani, David Brown · 2021 · JAMA Internal Medicine
Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin^|^ndash;Angiotensin System Activation in Experimental Type 1 Diabetes
Masumi Kamiyama, Andrea Zsombok, Hiroyuki Kobori · 2012 · Journal of Pharmacological Sciences
The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines
Luis Antonio Alcocer, Alfonso Bryce, David Brasil, Joffre J. Lara-Terán, Javier Moreno Cortes, Daniel Quesada, Pablo Rodriguez · 2023 · American Journal of Cardiovascular Drugs
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions
Leszek Tylicki, Sławomir Lizakowski, Boleslaw Rutkowski · 2012 · Journal of Nephrology
Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis
Junhui Gu, Ming Yang, Na Qi, Shuqin Mei, Jiejian Chen, Shuwei Song, Ying Jing, Meihan Chen, Liangliang He, Lijun Sun et al. · 2016 · Kidney & Blood Pressure Research
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
Jeffrey Wayne Stephens, Karen E. Brown, Thinzar Min · 2020 · Diabetes Obesity and Metabolism
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial
Hiddo J.L. Heerspink, Frederik Persson, Barry Morton Brenner, Nish Chaturvedi, Patrick Brunel, John J.V. McMurray, Akshay Suvas Desai, Scott David Solomon, Marc Alan Pfeffer, HANS-HENRIK D. PARVING et al. · 2016 · The Lancet Diabetes & Endocrinology
J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets
Deborah N. Kalkman, Tom F. Brouwer, Jim T. Vehmeijer, Wouter R. Berger, Reinoud E. Knops, Robbert J. de Winter, Ron J.G. Peters, Bert‐Jan H. van den Born · 2017 · Circulation
Versatile role of sirtuins in metabolic disorders: From modulation of mitochondrial function to therapeutic interventions
Ammara Afzaal, Kanwal Rehman, Shagufta Kamal, Muhammad Sajid Hamid Akash · 2022 · Journal of Biochemical and Molecular Toxicology
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients
Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Ikuo Saito, Kazuaki Shimamoto, Hiroaki Matsuoka, Kazuyuki Shimada, Sadayoshi Ito, Masatsugu Horiuchi, Tsutomu Imaizumi et al. · 2014 · Journal of Hypertension
The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice
Patricio A López-Jaramillo, José López-López, Cristina Lopez-Lopez, Miguel I Rodriguez-Alvarez · 2014 · Diabetology & Metabolic Syndrome
The Role of Beta-Blockers in the Treatment of Hypertension
John Malcolm Cruickshank · 2016 · Advances in experimental medicine and biology
A DS2-specific flavonoid-based probe with a unique dual-emissive response to human serum albumin
Yingying Huang, Taoyuze Lv, Tianyi Qin, Zhongyong Xu, Lei Wang, Bin Liu · 2020 · Chemical Communications
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
Giovanna Gallo, Massimo Volpe, Speranza Donatella Rubattu · 2022 · Vascular Health and Risk Management
Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients
Su Chi Lim, Jianjun Liu, Tavintharan Subramaniam, Chee Fang Sum · 2013 · Journal of the Renin-Angiotensin-Aldosterone System
Mineralocorticoid Antagonism and Diabetic Kidney Disease
Yuliya Lytvyn, Lucas C. Godoy, Rosalie Annemien Scholtes, Daniël H. van Raalte, David Z.I. Cherney · 2019 · Current Diabetes Reports
Systemic Inflammation Precedes Microalbuminuria in Diabetes
Florian Gunnar Scurt, Jan Menne, Sabine Brandt, Anja Bernhardt, Peter Rene Mertens, Hermann G. Haller, Christos Chatzikyrkou, Sadayoshi Ito, Josphe L. Izzo, Andrzeij Januszewicz et al. · 2019 · Kidney International Reports
Microalbuminuria breakthrough under chronic renin–angiotensin–aldosterone system suppression
César Cerezo, Luis Miguel Ruilope, J. Segura, José Antonio García‐Donaire, Juan J. de la Cruz, José R. Banegas, Bernard Waeber, Ton J. Rabelink, Franz H. Messerli · 2011 · Journal of Hypertension
The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation
Jan Menne, Eberhard Ritz, Luis Miguel Ruilope, Christos Chatzikyrkou, Giancarlo C. Viberti, Hermann G. Haller · 2014 · Journal of the American Heart Association
Mega clinical trials which have shaped the RAS intervention clinical practice
Rainer Düsing · 2016 · Therapeutic Advances in Cardiovascular Disease
Intensive blood pressure lowering in patients with and patients without type 2 diabetes: A pooled analysis from two randomized trials
Brouwer, Tom F., Vehmeijer, Jim T., Kalkman, Deborah N., Berger, Wouter R., van den Born, Bert-Jan H., Peters, Ron J., Knops, Reinoud E. · 2018 · Diabetes Care
CHANGING TRENDS IN END‐STAGE RENAL DISEASE DUE TO DIABETES IN THE UNITED KINGDOM
Christopher J. Hill, Damian G. Fogarty · 2012 · Journal of Renal Care
Obesity in kidney disease: A heavyweight opponent
Raphael José Ferreira Felizardo · 2014 · World Journal of Nephrology
Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME
André Jacques Scheen, Pierre Delanaye · 2017 · Diabetes & Metabolism
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
Raymond Camille Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodríguez, Alberto Ortíz · 2018 · Toxins
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death
Martin H. Strauss, Alistair S. Hall · 2015 · Progress in Cardiovascular Diseases
Renin Angiotensin Blockers and Cardiac Protection: From Basics to Clinical Trials
Bernard I Levy, Jean‐Jacques Mourad · 2021 · American Journal of Hypertension
Monocyte chemoattractant protein‐1 predicts the development of diabetic nephropathy
Florian Gunnar Scurt, Jan Menne, Sabine Brandt, Anja Bernhardt, Peter Rene Mertens, Hermann G. Haller, Christos Chatzikyrkou · 2021 · Diabetes/Metabolism Research and Reviews
Use of olmesartan and enteropathy outcomes: a multi‐database study
Yaa‐Hui Dong, Yinzhu Jin, Theodore Tsacogianis, Mengdong He, Pei-Ling Hsieh, Joshua J. Gagne · 2018 · Alimentary Pharmacology & Therapeutics
Olmesartan and Intestinal Adverse Effects in the ROADMAP Study
Jan Menne, Hermann G. Haller · 2012 · Mayo Clinic Proceedings
Present and Future in the Treatment of Diabetic Kidney Disease
Borja Quiroga, David Arroyo, Gabriel de Arriba · 2015 · Journal of Diabetes Research
Preventing and treating kidney disease in patients with type 2 diabetes
Pierre Delanaye, André Jacques Scheen · 2018 · Expert Opinion on Pharmacotherapy
Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment – systematic review and modelling of progression and cost-effectiveness
Andrew A. Farmer, Richard Stevens, Jennifer A. Hirst, Thomas Wai-Chun Lung, Jason Lee Oke, Philip Clarke, Paul Glasziou, Andrew Neil, David B. Dunger, Helen Martina Colhoun et al. · 2014 · Health Technology Assessment
Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis
Giuliano Tocci, Emanuele Barbato, Roberta Coluccia, Anna Modestino, Beniamino Pagliaro, Vittoria Mastromarino, Francesca Giovannelli, Andrea Berni, Massimo Volpe · 2015 · American Journal of Hypertension
Unbreakable? An analysis of the fragility of randomized trials that support diabetes treatment guidelines
B. Chase Kruse, Matt B. Vassar · 2017 · Diabetes Research and Clinical Practice
Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
Kei Fukami, Sho‐ichi Yamagishi, Melinda T. Coughlan, Brooke E. Harcourt, Phillip Kantharidis, Vicki Thallas‐Bonke, Seiya Okuda, Mark Emmanuel Cooper, Josephine Maree Forbes · 2014 · Diabetology & Metabolic Syndrome
Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
Tadashi Sofue, Hideyasu Kiyomoto, Hiroyuki Kobori, Maki Urushihara, Yoko Nishijima, Kumiko Kaifu, Taiga Hara, S. Matsumoto, Atsuhiko Ichimura, Hiroyuki Ohsaki et al. · 2012 · American Journal of Hypertension
Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus
George L. Bakris, Suzanne Oparil, Das Purkayastha, Anthony M. Yadao, Thomas R. Alessi, James R. Sowers · 2012 · Journal of Clinical Hypertension
Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: A cost‐effectiveness analysis
Bin Wu, Suhua Zhang, Hou‐Wen Lin, Shan Mou · 2017 · Journal of Diabetes Investigation
Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals
Thomas W. Winkler, Humaira Rasheed, Alexander Teumer, Mathias Gorski, Bryce X. Rowan, Kira J. Stanzick, Laurent F. Thomas, Adrienne Tin, Anselm Hoppmann, Audrey Y. Chu et al. · 2022 · Communications Biology
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
Jan Menne, Joseph L. Izzo, Sadayoshi Ito, Andrzej Januszewicz, Shigehiro Katayama, Christos Chatzykirkou, Albert Mimran, Ton J. Rabelink, Eberhard Ritz, Luis Miguel Ruilope et al. · 2012 · Journal of Hypertension